营收增长62%！一个韩束能否撑起上美股份的百亿野望？

Shangmei Co., Ltd. 2024 Financial Report Highlights

1. Revenue reached RMB 6.793 billion, a 62.08% year-on-year increase.

2. Gross profit was RMB 5.109 billion, up 69.22% year-on-year.

3. Annual profit totaled RMB 803 million, growing 74.00% year-on-year.

4. Net profit attributable to shareholders was RMB 781 million, a 69.42% increase.

Key Brand Performances

1. KANS contributed RMB 5.591 billion in revenue, accounting for 82.31% of total revenue with 80.92% growth; however, growth slowed from 143.84% in 2023.

2. ONE LEAF revenue declined 35.68% to RMB 229 million.

3. Red Elephant revenue grew marginally by 0.08% to RMB 376 million; both brands hit their lowest revenue levels from 2019 to 2024.

Future Corporate Strategy

1. Launching three new brands: high-end anti-aging skincare TAZU, maternal and infant care brand Anpanman, and color cosmetics brand NAN beauty.

2. Targeting RMB 10 billion revenue by 2025 and RMB 30 billion by 2030.

Brand Market Performance and Trends

1. KANS drives revenue growth but faces deceleration, with growth rate dropping from 143.84% to 80.92%, indicating potential slowdown risks.

2. Sharp declines in ONE LEAF and Red Elephant, hitting historic lows, highlight an imbalanced brand portfolio.

Brand Expansion and R&D Opportunities

1. New brand incubation: TAZU targets the high-end anti-aging market, Anpanman focuses on maternal and infant care, and NAN beauty enters the color cosmetics segment.

2. This strategy aims to reduce reliance on KANS and diversify the product lineup.

Consumer Trends and Goal Orientation

1. Overall 62% revenue growth reflects market potential; Chairman Lu Yixiong sets a 2025 target of RMB 10 billion.

2. The long-term 2030 target of RMB 30 billion guides strategic brand adjustments.

Growth Market and Risk Alerts

1. Shangmei's overall 62% growth is heavily reliant on KANS (82.31% revenue share).

2. Risks: ONE LEAF revenue fell 35.68%, while Red Elephant grew only 0.08%, revealing challenges in multi-brand management.

Opportunity Indicators and Countermeasures

1. New brand incubation offers entry points into new markets, such as TAZU, Anpanman, and NAN beauty.

2. The 2025 target of RMB 10 billion creates partnership and growth opportunities.

3. The company adopts diversification to mitigate single-brand dependency risks.

Key Takeaways and Business Models

1. Clear leadership targets: Lu Yixiong outlines a definitive growth roadmap.

2. Crisis response: Brand incubation as a risk-sharing measure offers lessons for peer companies.

Production Demand Analysis

1. New brand launches require production support: TAZU for high-end anti-aging skincare, Anpanman for maternal and infant care, and NAN beauty for color cosmetics.

2. 62% revenue growth and 69% gross profit growth signal increased production demand.

Business Opportunity Insights

1. The 2025 target of RMB 10 billion indicates potential production expansion, offering supply chain participation opportunities for factories.

2. A diversified brand portfolio presents product design collaboration possibilities.

Digital Transformation Implications

1. Although not explicitly detailed, growth data implies e-commerce trends; factories should monitor online production demands.

Industry Development Trends

1. Brand concentration: KANS dominates with 82.31% share, while other brands decline to historic lows.

2. New brand incubation trend: TAZU, Anpanman, and NAN beauty target different niche markets.

Client Pain Point Identification

1. Single-brand dependency risk: KANS growth slows, while ONE LEAF and Red Elephant decline.

2. Imbalanced growth demands require tailored solution support.

Solution Inspiration

1. Corporate strategy: New brand incubation drives diversification to address pain points.

2. Growth targets provide industry direction; service providers can design offerings around these goals.

Business Needs and Opportunities

1. New brand incubation requires platform partnerships for merchant acquisition: TAZU, Anpanman, and NAN beauty present potential collaboration targets.

2. 62% overall revenue growth demonstrates platform value potential.

Platform Operations and Risk Mitigation

1. The 2025 RMB 10 billion target creates opportunities for merchant recruitment and operational support.

2. Risk: Over-reliance on KANS (over 82% share) with slowing growth requires close monitoring.

Latest Practice Insights

1. The company's incubation strategy offers lessons in managing brand diversification for platforms.

2. Addressing imbalanced growth helps mitigate single-brand dependency risks.

Industry Developments

1. Shangmei's 62% revenue and 74% profit growth mask structural imbalance: KANS reaches a historic 82.31% share while other brands hit record lows.

2. New brand incubation (TAZU, Anpanman, NAN beauty) reflects industry expansion trends.

Emerging Issues

1. Over-reliance risk: KANS growth rate drops from 143.84% to 80.92%.

2. Brand deterioration: ONE LEAF revenue falls 35.68%, Red Elephant grows merely 0.08%.

Business Model Implications

1. Diversification strategy: New brand incubation mitigates concentration risks.

2. Target-setting (RMB 10B by 2025, RMB 30B by 2030) provides case study material and policy recommendation directions.